Stock CLDX CELLDEX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Real-time Estimate Cboe BZX
Other stock markets
 02:23:54 2024-05-21 pm EDT 		5-day change 1st Jan Change
37.62 USD -0.33% Intraday chart for Celldex Therapeutics, Inc. -4.99% -5.45%
May. 15 Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study MT
May. 15 Celldex Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLDX Stock
  4. News Celldex Therapeutics, Inc.
  5. MarketScreener Strategies
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW